Skip to Main Content
Contribute Try STAT+ Today

A catalyzing new review found virtually no research into ethics, security, and data rights of digital health measures — a worrying trifecta of blind spots for a field and an industry that will need the public’s trust to make a difference in health outcomes.

The promise of digital health measures like movement and heart rate have gained prominence during the pandemic, as doctor’s appointments shifted online and clinical trials were forced to go remote. Research into these measures is being steered both by academia and industry, including the tech titans whose wearable devices can drive the bulk of data collection.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment